
TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings
TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 第四届董事会第二十四次会议决议公告 | 2024-06-07 | Chinese | |
| 第四届监事会第二十三次会议决议公告 | 2024-06-07 | Chinese | |
| 关于前期会计差错更正后的财务报表及相关附注 | 2024-06-07 | Chinese | |
| 2023年年度报告(更正版) | 2024-06-07 | Chinese | |
| 关于前期会计差错更正的公告 | 2024-06-07 | Chinese | |
| 关于收到《民事判决书》暨诉讼进展公告 | 2024-06-07 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 38194236 | 第四届董事会第二十四次会议决议公告 | 2024-06-07 | Chinese | ||
| 38194219 | 第四届监事会第二十三次会议决议公告 | 2024-06-07 | Chinese | ||
| 38194204 | 关于前期会计差错更正后的财务报表及相关附注 | 2024-06-07 | Chinese | ||
| 38194171 | 2023年年度报告(更正版) | 2024-06-07 | Chinese | ||
| 38194071 | 关于前期会计差错更正的公告 | 2024-06-07 | Chinese | ||
| 38194056 | 关于收到《民事判决书》暨诉讼进展公告 | 2024-06-07 | Chinese | ||
| 38194038 | 天域生态环境股份有限公司前期会计差错事项说明专项审核报告 | 2024-06-07 | Chinese | ||
| 38193956 | 2022年年度报告(更正版 | 2024-06-07 | Chinese | ||
| 38193843 | 关于提前归还部分暂时用于补充流动资金的闲置募集资金的公告 | 2024-06-05 | Chinese | ||
| 38193835 | 关于担保债权人变更后公司继续提供担保的公告 | 2024-05-27 | Chinese | ||
| 38193831 | 关于公司2024年度对外担保预计的进展公告 | 2024-05-27 | Chinese | ||
| 38193819 | 关于控股股东所持股份解除质押的公告 | 2024-05-22 | Chinese | ||
| 38193806 | 德恒上海律师事务所关于天域生态环境股份有限公司2023年年度股东大会的法律意见书 | 2024-05-20 | Chinese | ||
| 38193797 | 2023年年度股东大会决议公告 | 2024-05-20 | Chinese | ||
| 38193765 | 关于2023年度业绩说明会召开情况的公告 | 2024-05-17 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
TIANYU BIO-TECHNOLOGY CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57798/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57798 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57798 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57798 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57798}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TIANYU BIO-TECHNOLOGY CO.,LTD. (id: 57798)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.